Alpha 2.0
Login Register
» Authors » Valeria Cardinali

Valeria Cardinali

Explore the profile of Valeria Cardinali including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 19
Citations 209
Followers 0
Related Specialties
Hematology
Oncology
General Medicine
Top 10 Co-Authors
Maria Paola Martelli
Giovanni Martino
Brunangelo Falini
Alessandra Venanzi
Sofia Sciabolacci
Enrico Tiacci
Stefano Ascani
Paolo Sportoletti
Andrea Marra
Monia Lunghi
Published In
Br J Haematol
Ann Hematol
Haematologica
Leukemia
N Engl J Med
Affiliations
Soon will be listed here.
Recent Articles
1.
Tyrosine kinase inhibitor discontinuation in non-allografted Philadelphia-positive acute lymphoblastic leukemia patients: a Campus ALL real-life study
Dragani M, Ansuinelli M, Papayannidis C, Fracchiolla N, Cardinali V, Cedrone M, et al.
Haematologica . 2025 Jan; PMID: 39781617
Not available.
2.
Starry sky pattern predicts RAS pathway activation in NPM1-mutated acute myeloid leukemia
Venanzi A, Cardinali V, Perriello V, Albano F, Cimino G, Martino G, et al.
Am J Hematol . 2024 Aug; 100(1):139-143. PMID: 39158266
No abstract available.
3.
The Leukemic Mutations Impair Myeloid and Erythroid Cell Differentiation of Primary Human Hematopoietic Stem and Progenitor Cells (HSPCs)
Pierangeli S, Donnini S, Ciaurro V, Milano F, Cardinali V, Sciabolacci S, et al.
Cancers (Basel) . 2024 Aug; 16(15). PMID: 39123404
How hematopoietic stem and progenitor cell (HSPC) fate decisions are affected by genetic alterations acquired during AML leukemogenesis is poorly understood and mainly explored in animal models. Here, we study...
4.
Ponatinib alone or with chemo-immunotherapy in heavily pre treated Philadelphia-like acute lymphoblastic leukemia: a CAMPUS ALL real-life study
Kaiser F, Lunghi M, Cardinali D, Bellomarino V, Beldinanzi M, Della Starza I, et al.
Haematologica . 2024 Aug; 109(12):4095-4099. PMID: 39086308
No abstract available.
5.
Prescription patterns of venetoclax in acute myeloid leukemia
Ucciero A, Traversa G, Pisterna A, Cardinali V, Sciabolacci S, Poloni A, et al.
Hematol Oncol . 2024 Jul; 42(4):e3298. PMID: 38989910
No abstract available.
6.
Correction to: One disease, two faces: clonally-related AML and MPDCP with skin involvement
Martino G, Cimino G, Caridi M, Perta G, Cardinali V, Sciabolacci S, et al.
Ann Hematol . 2023 Dec; 103(4):1421. PMID: 38150113
No abstract available.
7.
Blinatumomab Redirects Donor Lymphocytes against CD19 Acute Lymphoblastic Leukemia without Relevant Bystander Alloreactivity after Haploidentical Hematopoietic Stem Cell Transplantation
Mancusi A, Zorutti F, Ruggeri L, Bonato S, Tricarico S, Zei T, et al.
Int J Mol Sci . 2023 Nov; 24(22). PMID: 38003295
Blinatumomab alone or with donor leukocyte infusions (DLI) has been used after allogeneic hematopoietic stem cell transplantation (HSCT) as a salvage therapy in relapsing patients with CD19 hematological malignancies. It...
8.
One disease, two faces: clonally-related AML and MPDCP with skin involvement
Martino G, Cimino G, Caridi M, Perta G, Cardinali V, Sciabolacci S, et al.
Ann Hematol . 2023 Jul; 102(10):2969-2971. PMID: 37481474
No abstract available.
9.
Digital droplet PCR for T315I BCR::ABL1 KD mutation assessment in adult Ph-positive acute lymphoblastic leukemia with a minimal residual disease increase
Cardinali D, Beldinanzi M, Ansuinelli M, Elia L, Della Starza I, Bellomarino V, et al.
Leuk Lymphoma . 2023 Jul; 64(11):1884-1887. PMID: 37452789
No abstract available.
10.
NPM1-mutated AML with starry sky pattern
Falini B, Cardinali V, Brunetti L, Martelli M
Br J Haematol . 2023 May; 202(1):8. PMID: 37153969
No abstract available.